Human Kir2.1 Potassium Channel Cell Line
ChanTest CorporationHuman Kir2.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6103. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Identification and optimization of the chemical, series of chemicals or bio-molecule that will interact with the target using impartial, expert opinion about the best equipment, services and the latest techniques
Human Kir2.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6103. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human TRPV1 ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6105. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human Cav3.2 calcium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6106. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human CFTR chloride ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6113. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ HT
Using the LiChrolut® extraction unit simplifies solid-phase extraction and makes it more rapid and reliable. The drying attachment speeds up the drying process under controlled conditions. All the individual steps associated with solid-phase extraction can be carried out using the LiChrolut® extraction unit.
Human HCN2 hyperpolarization-gated ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6115. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Nav1.8/β3 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6011. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , IonWorks Quattro®
Human NMDA (NR1/NR2A) Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6120. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human NMDA (NR1/NR2B) Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6121. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human KCa1.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6122. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , QPatch™ HT , FLIPR®
Human kCa3.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6123. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™
Human Kir2.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6127. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quatto® , QPatch™HT
Human Kv1.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6130. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Kv1.2 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6131. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quatto® , QPatch™HT
Human Kv1.2 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6132. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Solid-phase extraction with LiChrolut® is a reliable and rapid route to successful sample preparation and the selective extraction of compounds from a complex sample. Three different modified SPE sorbents are available for non-polar solid-phase extraction: LiChrolut® RP-18 endcapped, LiChrolut® RP-18 and LiChrolut® RP-select B. The difference in polarities are clearly described by the adsorption characteristics. This can save…
Human Kv1.3 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6133. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quatto®
Human Kv1.3 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6134. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Kv1.4 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6135. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quatto® , QPatch™HT
Human Kv1.4 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6136. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Kv1.5 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6137. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: IonWorks Quattro®
Human Kv1.5 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6138. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Kv3.4 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6140. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Kv4.2/KChIP2.2 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6142. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: manual patch clamp
Human Kv4.3 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6143. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quatto® , QPatch™HT